» Articles » PMID: 22983436

Capture, Isolation and Release of Cancer Cells with Aptamer-functionalized Glass Bead Array

Overview
Journal Lab Chip
Specialties Biotechnology
Chemistry
Date 2012 Sep 18
PMID 22983436
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

Early detection and isolation of circulating tumor cells (CTC) can enable better prognosis for cancer patients. A Hele-Shaw device with aptamer functionalized glass beads is designed, modeled, and fabricated to efficiently isolate cancer cells from a cellular mixture. The glass beads are functionalized with anti-epidermal growth factor receptor (EGFR) aptamer and sit in ordered array of pits in polydimethylsiloxane (PDMS) channel. A PDMS encapsulation is then used to cover the channel and to flow through cell solution. The beads capture cancer cells from flowing solution depicting high selectivity. The cell-bound glass beads are then re-suspended from the device surface followed by the release of 92% cells from glass beads using combination of soft shaking and anti-sense RNA. This approach ensures that the cells remain in native state and undisturbed during capture, isolation and elution for post-analysis. The use of highly selective anti-EGFR aptamer with the glass beads in an array and subsequent release of cells with antisense molecules provide multiple levels of binding and release opportunities that can help in defining new classes of CTC enumeration devices.

Citing Articles

Facile, rapid and efficient isolation of circulating tumor cells using aptamer-targeted magnetic nanoparticles integrated with a microfluidic device.

Kajani A, Rafiee L, Samandari M, Mehrgardi M, Zarrin B, Javanmard S RSC Adv. 2022; 12(51):32834-32843.

PMID: 36425208 PMC: 9667373. DOI: 10.1039/d2ra05930d.


Efficient release of immunocaptured cells using coiled-coils in a microfluidic device.

Zhang M, Xu B, Siehr A, Shen W RSC Adv. 2022; 9(50):29182-29189.

PMID: 35528412 PMC: 9071837. DOI: 10.1039/c9ra03871j.


Three step flow focusing enables image-based discrimination and sorting of late stage 1 Haematococcus pluvialis cells.

Kraus D, Kleiber A, Ehrhardt E, Leifheit M, Horbert P, Urban M PLoS One. 2021; 16(3):e0249192.

PMID: 33780476 PMC: 8007022. DOI: 10.1371/journal.pone.0249192.


Electrochemical Detection and Point-of-Care Testing for Circulating Tumor Cells: Current Techniques and Future Potentials.

Lu C, Han J, Sun X, Yang G Sensors (Basel). 2020; 20(21).

PMID: 33114569 PMC: 7663783. DOI: 10.3390/s20216073.


Immunomagnetic separation of circulating tumor cells with microfluidic chips and their clinical applications.

Chen H, Li Y, Zhang Z, Wang S Biomicrofluidics. 2020; 14(4):041502.

PMID: 32849973 PMC: 7440929. DOI: 10.1063/5.0005373.


References
1.
Cheng J, Sheldon E, Wu L, Heller M, OConnell J . Isolation of cultured cervical carcinoma cells mixed with peripheral blood cells on a bioelectronic chip. Anal Chem. 1998; 70(11):2321-6. DOI: 10.1021/ac971274g. View

2.
Wan Y, Tan J, Asghar W, Kim Y, Liu Y, Iqbal S . Velocity effect on aptamer-based circulating tumor cell isolation in microfluidic devices. J Phys Chem B. 2011; 115(47):13891-6. DOI: 10.1021/jp205511m. View

3.
Nagrath S, Sequist L, Maheswaran S, Bell D, Irimia D, Ulkus L . Isolation of rare circulating tumour cells in cancer patients by microchip technology. Nature. 2007; 450(7173):1235-9. PMC: 3090667. DOI: 10.1038/nature06385. View

4.
Chapman K, Pullen N, Graham M, Ragan I . Preclinical safety testing of monoclonal antibodies: the significance of species relevance. Nat Rev Drug Discov. 2007; 6(2):120-6. DOI: 10.1038/nrd2242. View

5.
Paterlini-Brechot P, Benali N . Circulating tumor cells (CTC) detection: clinical impact and future directions. Cancer Lett. 2007; 253(2):180-204. DOI: 10.1016/j.canlet.2006.12.014. View